Plasma fibrinogen inhibits platelet adhesion in flowing blood to immobilized fibrinogen

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 5, 1996, Pages 633-638

  Endenburg, Silvia C ^c   Lindeboom Blokzijl, Laya ^c   Zwaginga, Jaap J ^a   Sixma, Jan J ^c   De Groot, Philip G ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

AFIBRINOGENEMIA; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMOBILIZATION; PERFUSION; PRIORITY JOURNAL; THROMBOCYTE ADHESION;

EID: 0029938021     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.5.633     Document Type: Article

References (53)

1. Ernst E. Fibrinogen. BMJ. 1991;303:596-597.
2. Qizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. BMJ. 1991;303:605-609.
3. Moller L, Kirstensen TS. Plasma fibrinogen and ischemic heart disease risk factors. Arterioscler Thromb. 1991;11:344-350.
4. Zwaginga JJ, Koomans HA, Sixma JJ, Rabelink TJ. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. J Clin Invest. 1994;93:204-211.
5. Meade TW, Vickers MV, Thompson SG, Seghatchian MJ. The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res. 1985;38:527-534.
6. Landolfi R, De Cristofaro R, De Candia E, Rocca B, Bizzi B. Effect of fibrinogen concentration on the velocity of platelet aggregation. Blood. 1991;78:377-381.
7. Cross MJ. Effect of fibrinogen on the aggregation of platelets by adenosine diphosphate. Thromb Diath Haem. 1964;12:524-527.
8. Peerschke EIB, Zucker MB, Grant RA, Egan JJ, Johnson MM. Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood. 1980;55:841-847.
9. Cattaneo M, Kinlough-Rathbone RL, Lecchi A, Bevilacqua C, Packham MA, Mustard JF. Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrino-genemic patients. Blood. 1987;70:221-226.
10. Peerschke EIB, Galanakis DK. Binding of fibrinogen to ADP-treated platelets. J Lab Clin Med. 1983;101:453-460.
11. Calvete JJ. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex. Thromb Haemost. 1994;72:1-15.
12. Smyth SS, Joneckis CC, Parise LV. Regulation of vascular integrins. Blood. 1993;81:2827-2843.
13. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
14. Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem. 1979;254:5357-5363.
15. Mustard JF, Packham MA, Kinlough-Rathbone RL, Perry DW, Regoeczi E. Fibrinogen and ADP-induced platelet aggregation. Blood. 1978;52:453-466.
16. Hawiger J, Parkinson S, Timmons S. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets. Nature. 1980;283:195-197.
17. Niiya K, Hodson E, Bader R, Byers-Ward V, Koziol JA, Plow EF, Ruggeri ZM. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation: relationship to the binding of fibrinogen and platelet aggregation. Blood. 1987; 70:475-483.
18. Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest. 1979;64:1393-1401.
19. Nachman RL, Leung LLK. Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J Clin Invest. 1982;69:263-269.
20. Savage B, Ruggeri ZM. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J. Biol Chem. 1991;266:11227-11233.
21. 3 mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem. 1992;267:11300-11306.
22. Hantgan RR, Hindriks GA, Taylor RG, Sixma JJ, De Groot PhG. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood. 1990;76:345-353.
23. Endenburg SC, Hantgan RR, Sixma JJ, De Groot PhG, Zwaginga JJ. Platelet adhesion to fibrin(ogen). Blood Coagul Fibrinolysis. 1993;4:139-142.
24. Jen CJ, Lin JS. Direct observation of platelet adhesion to fibrinogen- and fibrin-coated surfaces. Am J Physiol (Heart Circ Physiol). 1991;261:H1457-H1463.
25. Bini A, Fenoglio JJ Jr, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin and fibrin(ogen) degradation products in atherosclerosis: use of monoclonal antibodies. Arteriosclerosis. 1989;9:109-121.
26. Smith EB, Keen GA, Grant A, Stirk C. Fate of fibrinogen in human arterial intima. Arteriosclerosis. 1990;10:263-275.
27. Sheppeck RA, Bentz M, Dickson C, Hribar S, White J, Janosky J, Berceli SA, Borovetz HS, Johnson PC. Examination of the roles of glycoprotein Ib and glycoprotein IIb/IIIa in platelet deposition on an artificial surface using clinical antiplatelet agents and monoclonal antibody blockade. Blood. 1991;78:673-680.
28. Nagai H, Handa M, Kawai Y, Watanabe K, Ikeda Y. Evidence that plasma fibrinogen and platelet membrane GPIIb-IIIa are involved in the adhesion of platelets to an artificial surface exposed to plasma. Thromb Res. 1993;71:467-477.
29. Zucker MB, Vroman L. Platelet adhesion induced by fibrinogen adsorbed onto glass. Proc Soc Exp Biol Med. 1969;131:318-320.
30. Lindon JN, McManama G, Kushner L, Merril EW, Salzman EW. Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces? Blood. 1986;68:355-362.
31. Plow EF, Pierschbacher D, Ruoslahti E, Marguerie G, Ginsberg MH. Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets. Blood. 1987;70:110-115.
32. Andrieux A, Hudry-Clergeon G, Ryckewaert J-J, Chapel A, Ginsberg MH, Plow EF, Marguerie G. Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIb/IIIa. J Biol Chem. 1989;264:9258-9265.
33. Bennet JS, Shattil SJ, Power JW, Gartner TK. Interaction of fibrinogen with its platelet receptor: differential effects of α and γ chain fibrinogen peptides on the glycoprotein IIb-IIIa complex. J Biol Chem. 1988;263:12948-12953.
34. Lam SC-T, Plow EF, Smith A, Andrieux A, Ryckewaert J-J, Marguerie GA, Ginsberg MH. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen γ-chain peptides share a common binding site on platelets. J Biol Chem. 1987;262:947-950.
35. Gartner TK, Bennett JS. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem. 1985;260: 11891-11894.
36. Santoro SA, Lawing WJ Jr. Competition for related but non-identical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins. Cell. 1987;48: 867-873.
37. Hantgan RR, Endenburg SC, Cavero I, Marguerie G, Uzan A, Sixma JJ, De Groot PhG. Inhibition of platelet adhesion to fibrin(ogen) in flowing whole blood by Arg-Gly-Asp and fibrinogen γ-chain carboxy terminal peptides. Thromb Haemost. 1992;68: 694-700.
38. Kloczewiak M, Timmons S, Lukas TJ, Hawiger J. Platelet receptor recognition site on human fibrinogen: synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the γ-chain. Biochemistry. 1984;23:1767-1774.
39. Clauss A. Gerinnungsphysiologische schnell methode zur bestimmungs des fibringens. Acta Haematol. 1957;17:237-246.
40. Sakariassen KS, Aarts PAMM, De Groot PhG, Houdijk WP, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med. 1983;102: 522-535.
41. Van Breugel HHFI, De Groot PG, Heethaar R, Sixma JJ. Role of plasma viscosity in platelet adhesion. Blood. 1992;80:953-959.
42. Verhoeven AJM, Mommersteeg ME, Akkerman JWN. Quantification of energy consumption in platelets during thrombin-induced aggregation and secretion: tight coupling between platelet responses and the increment in energy consumption. Biochem J. 1984; 221:777-787.
43. Lowe GDO. Blood viscosity and cardiovascular disease. Thromb Haemost. 1992;67:494-498.
44. Lowe GDO. Blood rheology in arterial disease. Clin Sci. 1986;71: 137-146.
45. Harkness J. Measurement of plasma viscosity. In: Lowe GDO, Barbenel JC, Forbes CD, eds. Clinical Aspects of Blood Viscosity and Cell Deformability. Berlin, Germany: Springer-Verlag; 1981:79-87.
46. 3 with multiple fibrinogen domains during platelet adhesion. J Biol Chem. 1995;270:28812-28817.
47. Gralnick HR, Williams S, McKeown L, Connaghan G, Shafer B, Hansmann K, Vail M, Fenton J. Endogenous platelet fibrinogen surface expression on activated platelets. J Lab Clin Med. 1991;118:604-613.
48. Legrand C, Dubernard V, Nurden AT. Studies on the mechanism of expression of secreted fibrinogen on the surface of activated human platelets. Blood. 1989;73:1226-1234.
49. Courtois G, Ryckewaert J-J, Woods VL, Ginsberg MH, Plow EF, Marguerie GA. Expression of intracellular fibrinogen on the surface of stimulated platelets. Eur J Biochem. 1986;159:61-67.
50. Gralnick HR, Williams SB, McKeown L, Shafer B, Connaghan GD, Hansmann K, Vail M, Magruder L. Endogenous platelet fibrinogen: its modulation after surface expression is related to size-selective access to and conformational changes in the bound fibrinogen. Br J Haematol. 1992;80:347-357.
51. Endenburg SC, Jerome WG, Lewis JC, Sixma JJ, De Groot PhG. Does platelet-released von Willebrand factor support platelet adhesion to fibrin in flowing blood? Circulation. 1992;86(suppl I):I-417. Abstract.
52. Joist JH, Pennington DG. Platelet reactions with artificial surfaces. Trans Am Soc Artif Intern Organs. 1987;33:341-348.
53. Salzman EW, Lindon J, McManama G, Ware JA. Role of fibrinogen in activation of platelets by artificial surfaces. Ann N Y Acad Sci. 1981;516:184-192.